Bryan B. Molloy

2.8k total citations · 1 hit paper
62 papers, 2.3k citations indexed

About

Bryan B. Molloy is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Bryan B. Molloy has authored 62 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 22 papers in Molecular Biology and 16 papers in Organic Chemistry. Recurrent topics in Bryan B. Molloy's work include Neurotransmitter Receptor Influence on Behavior (23 papers), Neuroscience and Neuropharmacology Research (16 papers) and Receptor Mechanisms and Signaling (7 papers). Bryan B. Molloy is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (23 papers), Neuroscience and Neuropharmacology Research (16 papers) and Receptor Mechanisms and Signaling (7 papers). Bryan B. Molloy collaborates with scholars based in United States, United Kingdom and Germany. Bryan B. Molloy's co-authors include Ray W. Fuller, Frank P. Bymaster, Jong S. Horng, Kenneth W. Perry, Dawn M. Wong, David T. Wong, Harold D. Snoddy, Kenneth L. Hauser, Norman R. Mason and Norbert Neuss and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Bryan B. Molloy

61 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine

1974 374 citations Frank P. Bymaster, Bryan B. Molloy et al. Life Sciences profile →

Peers

Bryan B. Molloy

CMN

PHARM

PHYSI

Albert Weissman United States

Beng T. Ho United States

Alan A. Boulton Canada

W.P. Burkard Switzerland

Joseph P. Buckley United States

Peter G. Waser Switzerland

A. Horita United States

Anna L. Rényi Sweden

Harold D. Snoddy United States

Francis P. Miller United States

Albert Weissman United States

Bryan B. Molloy

1.6k ×1.4

CMN

791 ×0.9

405 ×1.0

PHARM

307 ×0.8

378 ×1.4

PHYSI

Citations per year, relative to Bryan B. Molloy Bryan B. Molloy (= 1×) peers Albert Weissman

Countries citing papers authored by Bryan B. Molloy

Since Specialization

Citations

This map shows the geographic impact of Bryan B. Molloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan B. Molloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan B. Molloy more than expected).

Fields of papers citing papers by Bryan B. Molloy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan B. Molloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan B. Molloy. The network helps show where Bryan B. Molloy may publish in the future.

Co-authorship network of co-authors of Bryan B. Molloy

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan B. Molloy. A scholar is included among the top collaborators of Bryan B. Molloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan B. Molloy. Bryan B. Molloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fuller, R W, Harold D. Snoddy, & Bryan B. Molloy. (1986). Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.. Journal of Pharmacology and Experimental Therapeutics. 239(2). 454–459. 20 indexed citations

Fuller, Ray W., Harold D. Snoddy, James A. Clemens, & Bryan B. Molloy. (1982). Effect of norfenfluramine and two structural analogues on brain 5-hydroxyindoles and serum prolactin in rats. Journal of Pharmacy and Pharmacology. 34(7). 449–450. 13 indexed citations

Fuller, Ray W., Norman R. Mason, & Bryan B. Molloy. (1980). Structural relationships in the inhibition of [3H]serotonin binding to rat brain membranes in vitro by 1-phenyl-piperazines. Biochemical Pharmacology. 29(5). 833–835. 53 indexed citations

Fuller, R W, et al.. (1980). p-Iodoamphetamine as a serotonin depletor in rats.. Journal of Pharmacology and Experimental Therapeutics. 212(1). 115–119. 15 indexed citations

Steinberg, Mitchell I. & Bryan B. Molloy. (1979). Clofilium1--a new antifibrillatory agent that selectively increases cellular refractoriness. Life Sciences. 25(16). 1397–1406. 43 indexed citations

Molloy, Bryan B., et al.. (1978). A32390A, a new biologically active metabolite. II. Isolation and structure.. The Journal of Antibiotics. 31(1). 27–32. 16 indexed citations

Fuller, Ray W. & Bryan B. Molloy. (1977). Inhibition in vitro of norepinephrine N-methyltransferase by 2-aminotetralins, analogs of phenylethylamines with rigid conformation. Biochemical Pharmacology. 26(5). 446–447. 6 indexed citations

Wong, David T., Bryan B. Molloy, & Frank P. Bymaster. (1977). Blockade of monoamine uptake by 1-amino-4-phenylbicyclo[2,2,2]octane (EXP 561) in rat brain and heart. Neuropharmacology. 16(1). 11–15. 10 indexed citations

Schmidt, Michael, et al.. (1976). Effects of kainic acid, a cyclic analogue of glutamic acid, on cyclic nucleotide accumulation in slices of rat cerebellum. Brain Research. 112(1). 113–126. 43 indexed citations

10.

Fuller, Ray W., John C. Baker, Kenneth W. Perry, & Bryan B. Molloy. (1975). Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolism. Neuropharmacology. 14(10). 739–746. 29 indexed citations

11.

Fuller, Ray W., Ken Perry, & Bryan B. Molloy. (1975). EFFECT OF 3-(p-TRIFLUOROMETHYLPHENOXY)-N-METHYL-3-PHENYLPROPYLAMINE ON THE DEPLETION OF BRAIN SEROTONIN BY 4-CHLOROAMPHETAMINE. Journal of Pharmacology and Experimental Therapeutics. 193(3). 796–803. 25 indexed citations

12.

Fuller, Ray W., Kenneth W. Perry, & Bryan B. Molloy. (1975). Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine.. PubMed. 193(3). 793–803. 93 indexed citations

13.

Fuller, Ray W., Kenneth W. Perry, Dawn M. Wong, & Bryan B. Molloy. (1974). Effects of some homologues of 4-chloroamphetamine on brain serotonin metabolism. Neuropharmacology. 13(7). 609–614. 7 indexed citations

14.

Fuller, Ray W., Harold D. Snoddy, & Bryan B. Molloy. (1973). EFFECT OF β,β-DIFLUORO SUBSTITUTION ON THE DISPOSITION AND PHARMACOLOGICAL EFFECTS OF 4-CHLOROAMPHETAMINE IN RATS. Journal of Pharmacology and Experimental Therapeutics. 184(1). 278–284. 4 indexed citations

15.

Fuller, Ray W., et al.. (1973). Further structure-activity studies on the lowering of brain 5-hydroxyindoles by 4-chloroamphetamine. Neuropharmacology. 12(1). 33–42. 17 indexed citations

16.

Fuller, Ray W., et al.. (1973). Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 2. In vitro and in vivo studies with 2,3-dichloro-.alpha.-methylbenzylamine. Journal of Medicinal Chemistry. 16(2). 106–109. 30 indexed citations

17.

Fuller, Ray W., et al.. (1973). CNS stimulant properties and physiologic disposition of ?,?-difluorophenylethylamine in mice. Psychopharmacology. 28(2). 205–212. 1 indexed citations

18.

Kinnel, Robin B., Bryan B. Molloy, Donald W. Graham, & Kenn E. Harding. (1972). 3-METHYL-3-BUTEN-1-OL AND 3-BUTEN-1-OL. Organic Preparations and Procedures International. 4(1). 27–30. 2 indexed citations

19.

Molloy, Bryan B., Richard M. Gale, Marvin Gorman, et al.. (1972). A NEW DIPEPTIDE ANTIBIOTIC FROM STREPTOMYCES COLLINUS, LINDENBEIN. The Journal of Antibiotics. 25(2). 137–140. 30 indexed citations

20.

Molloy, Bryan B., et al.. (1965). 805. Nuclear magnetic resonance. Part III. The structure of pyrrolo[2,1-b]thiazolium cations. Journal of the Chemical Society (Resumed). 4368–4368. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact